Structure	Chemical Name	CAS	MF
	(5β,9β,10α)-Beyer-15-en-3-one	28958-15-8	C20H30O
	(+)-15-Beyerene	3564-54-3	C20H32
	(5β,9β,10α)-Beyer-15-ene-3α,19-diol
	(5β,9β,10α)-Beyer-15-ene-3α,17-diol
	(-)-15-Beyerene	2359-73-1	C20H32
	(5β,9β,10α)-Beyer-15-ene-17,18-diol	5945-49-3	C20H32O2
	BEYER BROWN
	beyer-15-en-18-oic acid	120852-64-4	C20H30O2
	Bex1 protein
	BEZAFIBRATE , RITODRINE
	BEZAFIBRATE IMP. A (EP): N-(4-CHLOROBENZOYL)TYRAMINE MM(CRM STANDARD)
	BEZAFIBRATE IMP. D (EP): ETHYL 2-[4-[2-[(4-CHLOROBENZOYL)AMINO]ETHYL]PHENOXY]-2-METHYLPROPIONATE MM(CRM STANDARD)
	BEZAFIBRATE IMP. E (EP): BUTYL 2-[4-[2-[(4-CHLOROBENZOYL)AMINO]ETHYL]PHENOXY]-2-METHYLPROPIONATE MM(CRM STANDARD)
	BEZAFIBRATE IMP. C (EP): METHYL 2-[4-[2-[(4-CHLOROBENZOYL)AMINO]ETHYL]PHENOXY] MM(CRM STANDARD)
	bezafibroyl-coenzyme A	109881-30-3	C40H54ClN8O19P3S
	BEZAFIBRATE IMP. B (EP): 4-CHLOROBENZOIC ACID MM(CRM STANDARD)
	BEZAFIBRATE	63927-29-7	C19H20ClNO4
	Bezafibrate	41859-67-0	C19H20ClNO4
	B-110 FN 10 UL P/S SYRINGE
	B-110 FN 25 UL P/S SYRINGE
	B-110 FN 5 UL P/S SYRINGE
	B-110 FN 50 UL P/S SYRINGE
	Bezaldehyde		C7H6O
	BEZANTHRONE		C18H12O
	BfpA protein
	Bezapril
	BFP blue shifted GFP (Y66H):blue shifted GFP (Y66H)
	BfpB protein
	bexxar	208921-02-2
	B29 gene product	120300-00-7
	BfpE protein
	BFP/GFP FRET
	B-(4-Formyl-2-thienyl)boronic acid	1186026-19-6	C5H5BO3S
	BezindineYellowWb
	bezitramide	15301-48-1	C31H32N4O2
	Bezitramide hydrochloride	59708-44-0
	BGFNE
	Bezoar
	Bezoar artificaial
	B2F protein	151472-20-7
	BF-9 protocol
	BEZ235 (Tosylate)	1028385-32-1	C37H31N5O4S
	bfpT protein
	BfrA protein
	BfrB protein
	BfrC protein
	B-FREE
	BFRF1 protein
	BH 584	84777-88-8
	B7-H4
	BGIA protease inhibitor	136956-36-0
	BF-S BlueFlash
	bfr-1 protein	138880-50-9
	bfr-2 protein	138880-49-6
	BFR Recovery Spiking Standard Solution
	BG III toxin	156680-12-5
	BFR Spiking Solution
	Bg II toxin	156680-13-6
	BGJB MEDIUM
	BGJb Medium Fitton- Jackson Modification w/L-Glutamine (Powder)/without Phenol Red
	BGJb Medium Modified w/o L-Glutamine, Phenol Red (Powder)
	BGJb Medium Modified w/o L-Glutamine (Powder)
	BGJb Medium Fitton- Jackson Modification w/L-Glutamine (Powder)
	BGJ culture medium
	BH-AC-AMP protocol
	BHAC-DMPV protocol
	BH-AC-DMP protocol
	BHADIMER
	BFT3 protein
	BFT2 protein
	BFUI
	BfuI (BciVI)
	BGLB AGAR
	BHA-LYSINE-BOC DENDRIMER, GENERATION 1
	BHA-LYSINE-BOC DENDRIMER, GENERATION 0
	Bhangra
	11bH-Benzo(a)quinolizine, 1,2,3,4,6,7-hexahydro-2-beta-amino-9,10-dime thoxy-alpha-methyl-, dihydrochloride	39630-42-7	C16H24N2O2.2ClH
	9bH-Benz[e]indene-5,9b-diol, dodecahydro-3a-methyl-, (3aR,5S,5aS,9aS,9bR)-rel- (9CI)	491862-21-6	C14H24O2
	BglF protein
	BGLF2 protein
	BGLF4 protein
	BHA PS resin, 1% DVB (200-400 mesh)
	BHA PS resin, 1% DVB (100-200 mesh
	bharangin	72711-84-3	C20H24O4
	4bH,9bH,14bH-5,10,15-trioxa-14c-azabenzo[a]naphtho[1,2,3-de]anthracene
	BHC	608-73-1	C6H6Cl6
	BGL I	80449-04-3
	BFuroseMide IMp. B (EP)
	BGL II LINKER, 5'-PHOSPHORYLATED		C78H100N30O55P8
	BGL II LINKER
	BGL II LINKER, 5'-NON-PHOSPHORYLATED
	BGL II	81295-12-7
	6-b-Furylacryloylamidopenicillanic Acid, TEA Salt
	B-(2-FURYL)ACRYLICACID		C7H6O3
	B-2-FURYLETHANOL	35942-95-1	C6H8O2
	BglJ protein
	BHC (alpha isomer) (13C6) Solution
	BHC (alpha isomer) Solution
	BHA(UNSPECIFIED)
	BHC (beta isomer) Solution

549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709